Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cosgrove

Showing results (251-260 of 355) with videos related to

Pageof 36
Sort By:
Journal of the American Academy of Child and Adolescent Psychiatry|January 30, 2013
Early intervention for symptomatic youth at risk for bipolar disorder: a randomized trial of family-focused therapyDavid J Miklowitz, Christopher D Schneck, Manpreet K Singh, et al.
Infection Control and Hospital Epidemiology|February 14, 2014
Ventilator-associated pneumonia: overdiagnosis and treatment are common in medical and surgical intensive care unitsVeronique Nussenblatt, Edina Avdic, Sean Berenholtz, et al.
BMC Infectious Diseases|October 21, 2011
Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremiaMarin L Schweizer, Jon P Furuno, Anthony D Harris, et al.
Diabetes|June 24, 2000
Sulfonylurea receptor 1 and Kir6.2 expression in the novel human insulin-secreting cell line NES2YW M Macfarlane, R E O'Brien, P D Barnes, et al.
JAMA Network Open|July 6, 2022
Assessment of Changes in Visits and Antibiotic Prescribing During the Agency for Healthcare Research and Quality Safety Program for Improving Antibiotic Use and the COVID-19 PandemicSara C Keller, Tania M Caballero, Pranita D Tamma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 12, 2009
Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxicSara E Cosgrove, Gloria A Vigliani, Vance G Fowler, et al.
Brain, Behavior, and Immunity|May 8, 2020
Efficacy of adjunctive infliximab vs. placebo in the treatment of anhedonia in bipolar I/II depressionYena Lee, Rodrigo B Mansur, Elisa Brietzke, et al.
Journal of the American Geriatrics Society|January 17, 2022
Evaluating immunity to SARS-CoV-2 in nursing home residents using saliva IgGMorgan J Katz, Christopher D Heaney, Nora Pisanic, et al.
Journal of Molecular Endocrinology|October 3, 2013
Network analysis: a new approach to study endocrine disordersA Stevens, C De Leonibus, D Hanson, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2026
Comparative outcomes of ceftazidime-avibactam versus meropenem-vaborbactam for KPC-producing Enterobacterales infectionsSara M Karaba, Dariusz A Hareza, Jose M Munita, et al.
Pageof 36

Showing results (251-260 of 355) with videos related to

Sort By:
Pageof 36
Journal of the American Academy of Child and Adolescent Psychiatry|January 30, 2013
Early intervention for symptomatic youth at risk for bipolar disorder: a randomized trial of family-focused therapyDavid J Miklowitz, Christopher D Schneck, Manpreet K Singh, et al.
Infection Control and Hospital Epidemiology|February 14, 2014
Ventilator-associated pneumonia: overdiagnosis and treatment are common in medical and surgical intensive care unitsVeronique Nussenblatt, Edina Avdic, Sean Berenholtz, et al.
BMC Infectious Diseases|October 21, 2011
Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremiaMarin L Schweizer, Jon P Furuno, Anthony D Harris, et al.
Diabetes|June 24, 2000
Sulfonylurea receptor 1 and Kir6.2 expression in the novel human insulin-secreting cell line NES2YW M Macfarlane, R E O'Brien, P D Barnes, et al.
JAMA Network Open|July 6, 2022
Assessment of Changes in Visits and Antibiotic Prescribing During the Agency for Healthcare Research and Quality Safety Program for Improving Antibiotic Use and the COVID-19 PandemicSara C Keller, Tania M Caballero, Pranita D Tamma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 12, 2009
Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxicSara E Cosgrove, Gloria A Vigliani, Vance G Fowler, et al.
Brain, Behavior, and Immunity|May 8, 2020
Efficacy of adjunctive infliximab vs. placebo in the treatment of anhedonia in bipolar I/II depressionYena Lee, Rodrigo B Mansur, Elisa Brietzke, et al.
Journal of the American Geriatrics Society|January 17, 2022
Evaluating immunity to SARS-CoV-2 in nursing home residents using saliva IgGMorgan J Katz, Christopher D Heaney, Nora Pisanic, et al.
Journal of Molecular Endocrinology|October 3, 2013
Network analysis: a new approach to study endocrine disordersA Stevens, C De Leonibus, D Hanson, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2026
Comparative outcomes of ceftazidime-avibactam versus meropenem-vaborbactam for KPC-producing Enterobacterales infectionsSara M Karaba, Dariusz A Hareza, Jose M Munita, et al.
Pageof 36